Takeda Pharmaceutical Cash from Financing (TTM) Insights

Takeda Pharmaceutical Co Ltd (TAK)

13.23 -0.15 (-1.12%) USD | NYSE | Apr 24, 16:00

13.14 -0.09 (-0.68%) Pre-Market: 08:53

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2010. Upgrade now.

Date	Value
December 31, 2023	-2.274B
September 30, 2023	-4.688B
June 30, 2023	-4.008B
March 31, 2023	-5.252B
December 31, 2022	-7.247B
September 30, 2022	-5.489B
June 30, 2022	-7.443B
March 31, 2022	-9.534B
December 31, 2021	-10.66B
September 30, 2021	-12.31B
June 30, 2021	-12.23B
March 31, 2021	-10.27B
December 31, 2020	-8.205B
September 30, 2020	-5.622B
June 30, 2020	-9.423B
March 31, 2020	-9.249B
December 31, 2019	6.131B
September 30, 2019	19.88B
June 30, 2019	25.71B
March 31, 2019	26.58B
December 31, 2018	11.14B
September 30, 2018	-2.841B
June 30, 2018	-2.907B
March 31, 2018	-2.944B
December 31, 2017	831.87M

Date	Value
September 30, 2017	747.52M
June 30, 2017	849.16M
March 31, 2017	2.681B
December 31, 2016	588.57M
September 30, 2016	722.47M
June 30, 2016	714.37M
March 31, 2016	-1.040B
December 31, 2015	-2.614B
September 30, 2015	-2.536B
June 30, 2015	-2.690B
March 31, 2015	-2.752B
December 31, 2014	-1.605B
September 30, 2014	-1.809B
June 30, 2014	834.97M
March 31, 2014	963.50M
December 31, 2013
September 30, 2013
June 30, 2013
March 31, 2013
December 31, 2012
September 30, 2012
June 30, 2012
March 31, 2012
December 31, 2011
September 30, 2011

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-12.31B

Minimum

Sep 2021

25.71B

Maximum

Jun 2019

-3.799B

Average

-7.247B

Median

Dec 2022

Cash from Financing (TTM) Benchmarks